Lucid Diagnostics Inc. (LUCD) has a consensus analyst rating of Buy, based on 5 analysts covering the stock. Of those, 5 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for LUCD is $2.50, representing a +77.3% upside from the current price of $1.41. Price targets range from a low of $2.00 to a high of $3.00.
